Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Brain Research

• Publication date

  2013-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainres.2013.02.021PMID 23428542PMCID PMC3672394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function.

  2013cited by this paper
• Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

  2013influential reference
• Silencing of nicotinamide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells.

  2012cited by this paper
• Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.

  2012cited by this paper
• Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.

  2012cited by this paper
• Antioxidant characterization of soy derived products in vitro and the effect of a soy diet on peripheral markers of oxidative stress in a heart disease model.

  2012cited by this paper
• Biochemical investigation and gene analysis of equol: a plant and soy-derived isoflavonoid with antiaging and antioxidant properties with potential human skin applications.

  2012cited by this paper
• Continuous versus Cyclic Progesterone Exposure Differentially Regulates Hippocampal Gene Expression and Functional Profiles

  2012cited by this paper
• Androgen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein

  2012cited by this paper
• Isoflavones: estrogenic activity, biological effect and bioavailability

  2012cited by this paper
• R- and S-Equol have equivalent cytoprotective effects in Friedreich’s Ataxia

  2012cited by this paper
• Flavonoids and Cancer Prevention: A Review of the Evidence

  2012cited by this paper
• Inactivation and Reactivation of the Mitochondrial α-Ketoglutarate Dehydrogenase Complex*

  2011cited by this paper
• Estrogen receptor &bgr;-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause

  2011cited by this paper
• [Anti-invasion effects of R- and S-enantiomers of equol on prostate cancer PC3, DU145 cells].

  2011cited by this paper
• The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010)

  2011cited by this paper
• 2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Dietary genistein and equol (4', 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia.

  2010cited by this paper
• Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor &bgr;-agonist being developed for the treatment of menopausal symptoms

  2010cited by this paper
• Equol: history, chemistry, and formation.

  2010cited by this paper
• The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.

  2010influential reference
• Comparative Effects of R- and S-equol and Implication of Transactivation Functions (AF-1 and AF-2) in Estrogen Receptor-Induced Transcriptional Activity

  2010cited by this paper
• Equol: pharmacokinetics and biological actions.

  2010cited by this paper
• Soy phytoestrogens are neuroprotective against stroke-like injury in vitro.

  2009cited by this paper
• Frontiers proposal. National Institute on Aging “bench to bedside: estrogen as a case study”

  2009cited by this paper
• The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

  2009influential reference
• A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo.

  2009cited by this paper
• New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women

  2009influential reference
• Estrogen-induced plasticity from cells to circuits: predictions for cognitive function.

  2009cited by this paper
• Intermediary purine compounds formed during breakdown of ATP in blood.

  2009cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae.

  2008cited by this paper
• Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones

  2008influential reference
• Progesterone and estrogen regulate oxidative metabolism in brain mitochondria.

  2008cited by this paper
• The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications.

  2008cited by this paper
• Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?

  2007cited by this paper
• Estradiol In Vivo Regulation of Brain Mitochondrial Proteome

  2007cited by this paper
• Oxidants and antioxidants revisited. New concepts of oxidative stress

  2007cited by this paper
• The decrease in breast-cancer incidence in 2003 in the United States.

  2007cited by this paper
• Effects of soy phytoestrogens on the prostate

  2007cited by this paper
• Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient Fibroblasts

  2007cited by this paper
• WHI and WHIMS follow-up and human studies of soy isoflavones on cognition

  2007cited by this paper
• Alzheimer's APP mangles mitochondria

  2006cited by this paper
• Method of defining equol-producer status and its frequency among vegetarians.

  2006cited by this paper
• Equol: A Comparison of the Effects of the Racemic Compound With That of the Purified S-Enantiomer on the Growth, Invasion, and DNA Integrity of Breast and Prostate Cells In Vitro

  2006cited by this paper
• Mitochondria take center stage in aging and neurodegeneration

  2005cited by this paper
• Why females live longer than males? Importance of the upregulation of longevity‐associated genes by oestrogenic compounds

  2005cited by this paper
• S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.

  2005influential reference
• Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.

  2004influential reference
• Phytoestrogens.

  2004cited by this paper
• Phytoestrogens and breast cancer.

  2004cited by this paper
• Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.

  2004cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003influential reference
• The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

  2002cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones.

  1998cited by this paper
• Women's concerns with hormone replacement therapy‐ Compliance issues

  1994cited by this paper
• Brain α‐Ketoglutarate Dehydrogenase Complex: Kinetic Properties, Regional Distribution, and Effects of Inhibitors

  1986cited by this paper
• Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease.

  1984influential reference
• Experimental Biology and Medicine Minireview Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health

  year unknowncited by this paper

• Assessing the Roles of Aging, Estrogen, Nutrition, and Neuroinflammation in Women and Their Involvement in Alzheimer’s Disease—A Narrative Overview

  2026cites this paper
• Sex-Specific Diet–Microbiota Interactions in Ageing: Implications for Healthy Longevity

  2025cites this paper
• Postbiotics as a Therapeutic Tool in Alzheimer's Disease: Insights into Molecular Pathways and Neuroprotective Effects.

  2025cites this paper
• Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer’s disease

  2025cites this paper
• Bioavailability study of enantiopure (S)-Equol in CD(SD)IGS rats

  2025cites this paper
• Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition

  2025cites this paper
• Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms

  2024cites this paper
• Health benefits and future research of phytochemicals: a literature review.

  2024cites this paper
• Uncovering the Potential of O‐Prenylated 3‐Aryl‐benzopyran Derivatives as Osteogenic and Cancer Cell Growth Inhibitory Agents

  2024cites this paper
• From the gut to the brain: the long journey of phenolic compounds with neurocognitive effects

  2024cites this paper
• Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective

  2023cites this paper
• Allopregnanolone pleiotropic action in neurons and astrocytes: calcium signaling as a unifying mechanism

  2023cites this paper
• Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain

  2023cites this paper
• Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia

  2022cites this paper
• Mechanism of Soy Isoflavone Daidzein-Induced Female-Specific Anorectic Effect

  2022cites this paper
• Estrogenic flavonoids and their molecular mechanisms of action.

  2022cites this paper
• Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment

  2022cites this paper
• Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease

  2022cites this paper
• Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development

  2021cites this paper
• Pleiotropic Effects of Isoflavones in Inflammation and Chronic Degenerative Diseases

  2021cites this paper
• The Potential Effects of Phytoestrogens: The Role in Neuroprotection

  2021cites this paper
• Bioactivity of dietary polyphenols: The role of metabolites

  2020influential citation
• Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• The influence of phytoestrogens on different physiological and pathological processes: An overview

  2020cites this paper
• Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases

  2019cites this paper
• Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

  2019cites this paper
• Consumption of a soy drink has no effect on cognitive function but may alleviate vasomotor symptoms in post-menopausal women; a randomised trial

  2019cites this paper
• Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.

  2019cites this paper
• Current and emerging avenues for Alzheimer's disease drug targets

  2019cites this paper
• Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

  2019cites this paper
• Effects of 17β-Estradiol on Dopamine D2 Receptors in Thiamine-Deficient Female Rats: Consequences on Sucrose, Alcohol, Water Intakes and Body Weight

  2019cites this paper
• The effect of soya foods on cognitive function and menopausal symptoms in post-menopausal women

  2019cites this paper
• Soy-Induced Fecal Metabolome Changes in Ovariectomized and Intact Female Rats: Relationship with Cardiometabolic Health

  2018cites this paper
• A chiral pool approach for asymmetric syntheses of both antipodes of equol and sativan

  2018cites this paper
• Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease

  2018cites this paper
• Precision pharmacology for Alzheimer's disease.

  2018cites this paper
• Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

  2017cites this paper
• Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair

  2017cites this paper
• Daidzein and its Effects on Brain.

  2017cites this paper
• A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial

  2017cites this paper
• Exploring new chemical entities from traditional medicine: Docking, synthesis and specific bioactivities

  2016cites this paper
• Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

  2016cites this paper
• Optimization study on continuous separation of equol enantiomers using enantioselective liquid–liquid extraction in centrifugal contactor separators

  2016cites this paper
• The Isoflavonoid - Equol Isomer's Neurophysiological Effects After Short-term, Low-dose Administration in Male Rats

  2016cites this paper
• [A review of drugs for treatment of Alzheimer's disease in clinical trials: main trends].

  2016cites this paper
• The potential health effects of dietary phytoestrogens

  2016cites this paper
• Estrogen amelioration of Aβ-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ERβ, AKAP and Drp1.

  2015influential citation
• HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol

  2015cites this paper
• The Role of Colonic Bacteria in the Metabolism of the Natural Isoflavone Daidzin to Equol

  2015cites this paper
• HIV-1 AND COCAINE: MOTIVATION AND SYNAPTIC FUNCTION

  2015cites this paper
• S -Equol, a Metabolite of Soy Daidzein, and Cognitive Function

  2015cites this paper
• The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders

  2015cites this paper
• The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons

  2015cites this paper
• The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity.

  2015cites this paper
• Preparatory work to support the risk assessment for peri‐ and postmenopausal women taking food supplements containing isolated isoflavones

  2015cites this paper
• Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

  2014cites this paper
• Estrogen: a master regulator of bioenergetic systems in the brain and body.

  2014cites this paper
• Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner

  2014cites this paper
• Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities

  2014cites this paper
• Antioxidant characterization of soy derived products in vitro and the effect of a soy diet on peripheral markers of oxidative stress in a heart disease model.

  2012cites this paper